Analysis: A tale of three pharma companies and a quarter

Cipla beat expectations riding the demand for Covid medication. The Street is likely to push the stock to its record high hit in 2015. While US business revenues declined, the company's domestic business sales grew in double-digits.

from Markets-Economic Times https://ift.tt/3gKZSk7